Hudson Pharma

What Hudson Pharma does

Hudson Pharma is a Pakistan-based, private branded generic pharmaceutical company founded in 2010, operating a multi-therapeutic portfolio across Respiratory, Injectables, Ophthalmic, and Dermatology. Its stated strategy is to identify proven first-line treatments that are unavailable in the markets it serves and commercialize them through novel delivery methods and proprietary manufacturing processes, positioning the company as a first-to-market entrant in those geographies. Core launched products include respiratory medications for asthma and COPD, injectables for bacterial infections, fevers, pain, and iron-deficient anemia, and ophthalmic products including the Teardrop (Polyethylene Glycol 0.4% / Propylene Glycol 0.3%) line for dry eye; the Dermatology segment is staged as 'Coming Soon.'

The company's underlying technology centers on a state-of-the-art manufacturing facility equipped with highly automated equipment and monitoring technology that eliminates human interaction during production. Differentiation rests on novel delivery methods and novel manufacturing processes that are claimed to improve safety and affordability relative to alternative supply in target markets. The Dermatology portfolio is not yet commercially launched, indicating active but incomplete segment build-out.

Hudson Pharma operates a sales-led, B2B go-to-market motion targeting doctors, healthcare professionals, and pharmaceutical distribution networks within Pakistan. Revenue is generated through product sales across therapeutic segments, with pricing negotiated through healthcare providers and payers rather than publicly disclosed. No funding rounds, acquisitions, partnerships, leadership hires, or certifications were disclosed in the source material, and the company maintains an active corporate website with product pages, healthcare-professional resources, and a COVID-19 information hub.

Name

Hudson Pharma

Legal name

Hudson Pharma

Website

https://hudsonpharma.com

Company type

Private

Founded year

2010

Operating status

Operating

Headcount range

251–500 employees

Short description

Hudson Pharma is a Pakistan-based branded generic pharmaceutical company that commercializes proven first-line therapies through novel delivery methods and automated manufacturing, serving doctors and patients across Respiratory, Injectables, Ophthalmic, and forthcoming Dermatology segments.

Ownership category

akta.pro rank

Product category

Branded Generic Pharmaceuticals

NAICS

Pharmaceutical Preparation Manufacturing (325412), Pharmaceutical and Medicine Manufacturing (32541)

SIC

Pharmaceutical Preparations (2834)

akta.pro primary industry

Primary Care & General Medicine Pharmaceuticals (HLAIAAAA)

akta.pro secondary industries

Ophthalmology Pharmaceuticals (HLAIAAAL), Generic Hospital & Institutional Products (HLAIABAL)

Keywords

• Branded generic pharmaceuticals
• Respiratory medications
• Ophthalmic treatments
• Injectable therapeutics
• Dermatology pharmaceuticals

Headquarters

HQ city

Pakistan Kili

HQ country

Pakistan

HQ region

Asia

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Branded Generic Pharmaceutical Products: Revenue generated through the sale of branded generic pharmaceutical products across therapeutic segments including Respiratory, Injectables, Ophthalmic, and Dermatology. The company identifies proven first-line treatments and brings them to market through novel delivery methods and manufacturing processes.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels2 records

Core offering

Hudson Pharma is a branded generic pharmaceutical company that identifies proven first-line treatments and brings them to market through novel delivery methods and manufacturing processes. Its portfolio spans four therapeutic segments: Respiratory (asthma, COPD), Injectables (bacterial infections, fevers, pain, iron-deficient anemia), Ophthalmic (glaucoma, dry eye — including the Teardrop product), and Dermatology (acne, topical fungal infections — coming soon).

Product overview

Hudson Pharma is a branded generic pharmaceutical company organized as a single-brand portfolio with four core therapeutic segments: Respiratory, Injectables, Ophthalmic, and Dermatology. The Respiratory segment treats asthma and COPD; Injectables cover bacterial infections, fevers, pain, and iron-deficient anemia; Ophthalmic includes the Teardrop product line for glaucoma and dry eye; and Dermatology addresses acne and topical fungal infections. Products are designed to deliver first-line therapies that were previously unavailable in their markets, leveraging novel delivery methods and manufacturing processes.

Differentiator

Problem solved

Functional benefit

Brands

• Teardrop: Polyethylene Glycol 0.4% / Propylene Glycol 0.3% ophthalmic product for treating dry eye conditions, including post-operative dry eye.

Products and services

• Respiratory Products Branded generic respiratory medications for the treatment of asthma and chronic obstructive pulmonary disease (COPD). One of Hudson Pharma's four core therapeutic segments, prescribed by healthcare professionals for patients with respiratory conditions.
• Injectables Branded generic injectable pharmaceutical products for treating bacterial infections, fevers, pain, and iron-deficient anemia. One of Hudson Pharma's core therapeutic segments, administered through healthcare providers.
• Ophthalmic Products Branded generic ophthalmic medications for the treatment of glaucoma and dry eye conditions, including post-operative dry eye. One of Hudson Pharma's core therapeutic segments, includes the Teardrop product line.
• Teardrop Ophthalmic solution containing Polyethylene Glycol 0.4% and Propylene Glycol 0.3% for treating dry eye conditions, including post-operative dry eye. Sub-brand under Hudson Pharma's Ophthalmic product segment.

Segments6 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Scale indicators2 records

Recent moves1 record

Expansion highlights4 records

Direct peers

• AGP Limited: Major Pakistan-based pharmaceutical manufacturer offering branded generics and specialty products across multiple therapeutic categories. Closely comparable in terms of headcount scale, manufacturing footprint, and domestic branded-generic positioning.
• The Searle Company: One of Pakistan's largest branded generic manufacturers, with a broad therapeutic portfolio including respiratory, ophthalmic, and dermatology segments. Comparable to Hudson Pharma in geographic footprint, product breadth, and branded-generic positioning.
• Bosch Pharmaceuticals: Pakistan-based pharmaceutical company with a branded generics portfolio spanning multiple therapeutic areas including ophthalmic and respiratory. Directly comparable in product mix and physician-targeted sales motion.
• Getz Pharma: Pakistan-based pharmaceutical manufacturer with a multi-therapeutic branded generics portfolio. Directly comparable to Hudson Pharma in business model, geographic focus, and sales-led GTM targeting physicians across respiratory, dermatology, and other therapeutic segments.
• Highnoon Laboratories: Pakistan-based branded generic pharmaceutical manufacturer with diversified therapeutic segments including respiratory, ophthalmic, and injectables. Directly comparable in scale, therapeutic breadth, and domestic sales-led GTM.
• Sami Pharmaceuticals: Pakistan-headquartered pharmaceutical company focused on branded specialty generics across multiple therapeutic areas. Comparable to Hudson Pharma in branded-generic business model and Pakistan-domestic orientation.

Regional players

• PharmEvo: Pakistan-based pharmaceutical company with branded generics across multiple therapeutic categories. Comparable in business model and regional focus, operating in the same domestic market as Hudson Pharma with overlapping therapeutic segments.

Broad incumbents

• Abbott Pakistan: Multinational pharma's Pakistan subsidiary with a diversified branded-generic and innovator portfolio. Comparable in therapeutic segments served but operates at significantly larger scale with global R&D and brand equity behind its products.
• GlaxoSmithKline Pakistan: Multinational pharma's Pakistan subsidiary offering both branded innovator and generic products across respiratory, dermatology, and ophthalmic categories. Comparable therapeutic overlap but with much broader portfolio and stronger brand recognition than Hudson Pharma.
• Sanofi Pakistan: Multinational pharma's Pakistan subsidiary offering branded pharmaceuticals across multiple therapeutic areas. Comparable in Pakistan-domestic branded positioning but with substantially stronger global brand equity and R&D pipeline.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xx.com/HudsonPharma

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Hudson Pharma